MDGL - Madrigal Pharmaceuticals (MDGL) Q1 2024 Earnings Call Transcript
2024-05-07 11:24:02 ET
Madrigal Pharmaceuticals (MDGL)
Q1 2024 Results Conference Call
May 07, 2024 8:00 AM ET
Company Participants
Tina Ventura - Chief IRO
Bill Sibold - CEO
Mardi Dier - CFO
Conference Call Participants
Yasmeen Rahimi - Piper Sandler
Eli Merle - UBS
Liisa Bayko - Evercore
Jay Olson - Oppenheimer
Ritu Baral - TD Cowen
Thomas Smith - Leerink Partners
Akash Tewari - Jefferies
Jon Wolleben - Citizens
Andrea Tan - Goldman Sachs
Presentation
Operator
Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals First Quarter 2024 Earnings Conference Call. [Operator Instructions]. As a reminder, today's conference is being recorded.
I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. Please go ahead.
Tina Ventura
Thank you, Lisa. Good morning, everyone, and thank you for joining us to discuss Madrigal's first quarter 2024 earnings call. We issued a press release this morning. There's also a supplementary slide deck that accompanies this webcast and that will post immediately following the call on the Investor Relations section of our website.
On the call with me today is Bill Sibold, Chief Executive Officer; and Mardi Dier, Chief Financial Officer. They'll provide prepared remarks, and then we'll take your questions. We're shooting to keep today's call to about 45 minutes. Please note we'll be making certain forward-looking statements today. We refer you to our SEC filings for a discussion of the risks that may cause actual results to differ from the forward-looking statements. ...
Madrigal Pharmaceuticals (MDGL) Q1 2024 Earnings Call Transcript